MetaCap

Boston Scientific (BSX) vs Medline (MDLN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Boston Scientific is the larger company by market cap ($60.85 billion vs $48.75 billion), about 1.2 times the size. On valuation, Boston Scientific trades at a lower forward P/E (13.4x vs 24.0x for Medline). Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 4.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BSX-55.57%MDLN-9.66%
+26%-17%-60%
Dec 17, 20251 yearNov 20, 2026
BSX-56.09%MDLN-11.07%
+23%-18%-60%
Dec 15, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BSX versus MDLN key metrics
MetricBSXMDLN
Share price$41.98$37.04
Market cap$60.85B$48.75B
1-day change-2.35%-2.11%
YTD return-55.97%-11.81%
1-year return-56.67%—
5-year return+8.84%—
P/E ratio (TTM)17.7184.18
Forward P/E13.4123.98
EPS (TTM)$2.37$0.44
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$20.07B$28.43B
Revenue growth (YoY)+19.87%—
Net income (latest FY)$2.89B$1.16B
Gross margin69.01%26.44%
Operating margin18.00%7.78%
Net margin14.41%4.08%
52-week high$101.91$50.88
52-week low$39.57$31.37
Distance from 52-week high-58.81%-27.20%
Analyst consensusbuybuy
Avg. price target upside+18.15%+23.52%
Average volume19.19M9.55M
Shares outstanding1.45B878.66M
Employees59,00045,000
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Medline trades at a higher earnings multiple (84.2x vs 17.7x trailing P/E).
  • Boston Scientific is more profitable, keeping 14.4 cents of every revenue dollar as net income versus 4.1 cents for Medline.

About Boston Scientific

BSX stock →

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Health Care · Medical/Dental Instruments · 59,000 employees

About Medline

MDLN stock →

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.

Health Care · Medical/Dental Instruments · 45,000 employees

BSX vs MDLN FAQ

Which is bigger, Boston Scientific or Medline?

Boston Scientific (BSX) is larger, with a market capitalization of $60.85B compared with $48.75B for Medline (MDLN).

Which has the lower P/E ratio, BSX or MDLN?

BSX has the lower trailing P/E at 17.7, versus 84.2 for MDLN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Boston Scientific and Medline in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons